You don't need to be signed in to read BMJ Group Blogs, but you can register here to receive updates about other BMJ Group products and services via our Group site.

Hib-MenC-TT immunisation

14 May, 08 | by Ian Wacogne

The antibody titres against Hib and MenC wane into the second year of life; a Hib-MenC-TT immunisation at 12-15 months boosted these levels in a phase III trial conducted in the UK and Poland.  Here.

Posted in Immunisation.
Respond
Print page

Leave a Reply

You can follow any responses to this entry through the RSS 2.0 feed.
« Mucopolysaccharidosis
Immunisation status and MMR uptake »

ADC Online

A peer review journal for health professionals and researchers covering conception to adolescence. Visit site

BMJ Clinical Evidence updates